The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 443,863 shares of the medical device company's stock after acquiring an additional 6,489 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.22% of Cooper Companies worth $48,976,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Cooper Companies by 43.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company's stock valued at $3,076,000 after purchasing an additional 10,616 shares during the period. Axxcess Wealth Management LLC increased its stake in shares of Cooper Companies by 298.4% during the first quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company's stock valued at $833,000 after buying an additional 6,150 shares during the period. Public Employees Retirement Association of Colorado raised its holdings in shares of Cooper Companies by 298.9% in the first quarter. Public Employees Retirement Association of Colorado now owns 245,793 shares of the medical device company's stock valued at $24,938,000 after acquiring an additional 184,171 shares in the last quarter. Diversify Advisory Services LLC purchased a new stake in Cooper Companies in the second quarter worth about $501,000. Finally, BDF Gestion purchased a new stake in Cooper Companies in the second quarter worth about $2,919,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insider Buying and Selling

In other news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Agostino Ricupati sold 1,601 shares of the business's stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company's stock, valued at $520,488.54. This represents a 24.94 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 256,373 shares of company stock valued at $27,637,427. Corporate insiders own 2.00% of the company's stock.

Cooper Companies Stock Performance

NASDAQ COO traded down $0.23 on Friday, hitting $99.63. 1,415,083 shares of the company's stock traded hands, compared to its average volume of 1,126,768. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The firm's 50-day moving average price is $106.83 and its two-hundred day moving average price is $98.00. The Cooper Companies, Inc. has a 1-year low of $82.21 and a 1-year high of $112.38. The firm has a market capitalization of $19.84 billion, a PE ratio of 55.50, a P/E/G ratio of 2.20 and a beta of 0.99.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. During the same quarter last year, the business posted $0.84 EPS. The company's revenue was up 7.8% on a year-over-year basis. As a group, analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently commented on COO. Morgan Stanley boosted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an "equal weight" rating in a report on Tuesday, September 10th. Stifel Nicolaus reaffirmed a "buy" rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird boosted their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, August 29th. Wells Fargo & Company raised their price objective on Cooper Companies from $110.00 to $115.00 and gave the company an "overweight" rating in a research report on Thursday, August 29th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.